Talaba, Shyra J.
HRN: 16-13-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2024
CEFUROXIME 500MG (TAB)
01/09/2024
01/16/2024
ORAL
500mg
BID
NSVD With Right Mediolateral Episiorrhapy
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes